# Trade Mark Journal No.2025/052 26 December 2025

## WO0000001890955 (5)

Office of origin: United States of America

Date of International Registration:11 November 2025
Date of designation in the UK: 11 November 2025

Class 5
  Pharmaceutical preparations for the treatment of erythropoietic porphyria (EPP), X-linked protoporphyria (XLPP), genetic diseases and disorders, dermatological diseases and disorders, hematological diseases and disorders, liver diseases and disorders, and photosensitivity.

Disc Medicine, Inc.

Representative: Christina M. Licursi Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210-2206, UNITED STATES OF AMERICA